文献速递心血管MR

人类高血压中醛固酮相关心肌细胞外基质扩张:心脏磁共振的概念验证研究

Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-09-16

本研究纳入原发性醛固酮增多症、原发性高血压、Bartter/Gitelman综合征所致继发性醛固酮增多症及健康对照各20例,用心脏磁共振T1 mapping定量左室细胞内外质量指数。仅原发性醛固酮增多症合并高血压者细胞外质量指数较其他组高30%,且校正平均血压后仍显著;血压正常的继发性醛固酮增多症不影响细胞外基质。

要点

  • 原发性醛固酮增多症合并高血压者细胞外质量指数较其他组高30%,校正平均血压后仍显著。
  • 血压正常的继发性醛固酮增多症者细胞外质量指数与健康对照及原发性高血压者相似。
  • 细胞内质量指数随血压升高而增加,各组间差异显著。

诊断标准与关键数值

  • 血浆醛固酮浓度中位数:原发性醛固酮增多症709 pmol/l(IQR 430–918),原发性高血压197 pmol/l(IQR 121–345),Bartter/Gitelman综合征297 pmol/l(IQR 180–428),健康受试者105 pmol/l(IQR 85–227)。
  • 收缩压:原发性醛固酮增多症147±15 mm Hg,原发性高血压133±19 mm Hg,Bartter/Gitelman综合征116±9 mm Hg,健康受试者117±12 mm Hg。
  • 左室舒张末期容积:Bartter/Gitelman综合征63±13 ml/m2 vs 原发性醛固酮增多症82±15 ml/m2,p<0.0001。
  • 细胞内质量指数:Bartter/Gitelman综合征36(IQR 29–41),健康受试者40(IQR 36–46),原发性高血压51(IQR 42–54),原发性醛固酮增多症50(IQR 46–67),p<0.0001。
  • 细胞外质量指数:Bartter/Gitelman综合征16(IQR 12–20),健康受试者15(IQR 11–18),原发性高血压14(IQR 12–17),原发性醛固酮增多症21(IQR 18–29)较其他组高30%,p<0.0001,校正平均血压后仍显著。

临床应用与阅片要点

  • 心脏磁共振T1 mapping可无创量化心肌细胞外质量指数,用于评估醛固酮相关心肌纤维化。
  • 原发性醛固酮增多症合并高血压患者细胞外基质扩张独立于血压水平,阅片时需结合临床醛固酮状态解读T1 mapping结果。
  • 血压正常的继发性醛固酮增多症患者细胞外质量指数未见升高,提示醛固酮对细胞外基质的影响需合并高血压才显现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to assess the respective effects of aldosterone and blood pressure (BP) levels on myocardial fibrosis in humans.

BACKGROUND: Experimentally, aldosterone promotes left ventricular (LV) hypertrophy, and interstitial myocardial fibrosis in the presence of high salt intake.

METHODS: The study included 20 patients with primary aldosteronism (PA) (high aldosterone and high BP), 20 patients with essential hypertension (HTN) (average aldosterone and high BP), 20 patients with secondary aldosteronism due to Bartter/Gitelman (BG) syndrome (high aldosterone and normal BP), and 20 healthy subjects (HS) (normal aldosterone and normal BP). Participants in each group were of similar age and sex distributions, and asymptomatic. Cardiac magnetic resonance including cine and T1 mapping was performed blind to the study group to quantify global LV mass index, as well as intracellular mass index and extracellular mass index considered as a measure of myocardial fibrosis in vivo.

RESULTS: Median plasma aldosterone concentration was as follows: PA = 709 pmol/l (interquartile range [IQR]: 430 to 918 pmol/l); HTN = 197 pmol/l (IQR: 121 to 345 pmol/l); BG = 297 pmol/l (IQR: 180 to 428 pmol/l); and HS = 105 pmol/l (IQR: 85 to 227 pmol/l). Systolic BP was as follows: PA = 147 ± 15 mm Hg; HTN = 133 ± 19 mm Hg; BG = 116 ± 9 mm Hg; and HS = 117 ± 12 mm Hg. LV end-diastolic volume showed underloading in BG and overloading in patients with PA (63 ± 13 ml/m2 vs. 82 ± 15 ml/m2; p < 0.0001). Intracellular mass index increased with BP across groups (BG: 36 [IQR: 29 to 41]; HS: 40 [IQR: 36 to 46]; HTN: 51 [IQR: 42 to 54]; PA: 50 [IQR: 46 to 67]; p < 0.0001). Extracellular mass index was similar in BG, HS, and HTN (16 [IQR: 12 to 20]; 15 [IQR: 11 to 18]; and 14 [IQR: 12 to 17], respectively) but 30% higher in PA (21 [IQR: 18 to 29]; p < 0.0001) remaining significant after adjustment for mean BP.

CONCLUSIONS: Only primary pathological aldosterone excess combined with high BP increased both extracellular myocardial matrix and intracellular mass. Secondary aldosterone excess with normal BP did not affect extracellular myocardial matrix. (Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism; NCT02938910).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Redheuil A, Blanchard A, Pereira H, et al. Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2020. PMID: 32950448. doi:10.1016/j.jcmg.2020.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。